Our clinical proficiency testing schemes, or external quality assessment schemes, deal principally in the area of drug monitoring, whether of deliberately administered drugs for therapeutic purposes, toxic drugs deliberately or accidentally ingested which could cause harm, or drugs of abuse which may be analysed for clinically significant levels or for workplace monitoring.

Due to the importance of results obtained, it is essential that laboratories are able to demonstrate their testing is dependable, reproducible and accurate; otherwise mistakes can have a major impact on patient care, legal and forensic investigations, occupational monitoring, insurance screening and more.